Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1638
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17611511 | MPS MODIFIED PEPTIDES AND USE THEREOF | Final Rejection | The Regents of the University of California |
| 17783473 | USE OF POLYVINYL ALCOHOL FOR CELL CULTURE OF IMMUNE CELLS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 16985432 | CHIMERIC ANTIGEN RECEPTORS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS | Final Rejection | THE TRUSTEES OF DARTMOUTH COLLEGE |
| 17916683 | METHODS TO ENRICH ENTEROENDOCRINE CELLS AND THEIR SUBTYPES IN THE CONTIGUOUS, INTESTINAL MONOLAYER SYSTEMS | Non-Final OA | University of Washington |
| 17042007 | USE OF EXOSOMES FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17924040 | METHODS AND COMPOSITIONS FOR MAKING AND USING ENDOCARDIAL CELLS | Non-Final OA | University Health Network |
| 17908585 | METHOD FOR NATURAL KILLER CELL EXPANSION | Non-Final OA | ACADEMIA SINICA |
| 17323715 | GENERATION OF HOXA-EXPRESSING HEMOGENIC ENDOTHELIUM WITH ENHANCED T CELL POTENTIAL FROM HPSCS | Non-Final OA | Wisconsin Alumni Research Foundation |
| 17429391 | GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCS) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES | Non-Final OA | The United States of America,as represented by the Secretary,Department of Health and Human Services |
| 17755732 | CUSTOMIZABLE 3D CELL CULTURE SYSTEM COMPRISING HYDROGEL-EMBEDDED CELLS AND USES THEREOF | Final Rejection | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY |
| 18004151 | COMPOSITIONS AND METHODS FOR CELLULAR REPROGRAMMING USING CIRCULAR RNA | Non-Final OA | ElevateBio Technologies, Inc. |
| 18284129 | METHOD FOR PRODUCING OVARIAN SOMATIC CELL-LIKE CELLS, AND METHOD FOR INDUCING DIFFERENTIATION OF PRIMATE PLURIPOTENT STEM CELLS INTO OVARIAN SOMATIC CELL-LIKE CELLS | Non-Final OA | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION |
| 18018787 | IN VITRO DIFFERENTIATION OF PANCREATIC ENDOCRINE CELLS | Non-Final OA | VERTEX PHARMACEUTICALS INCORPORATED |
| 18006684 | COMPOSITION FOR PREVENTING HEARING LOSS CONTAINING MESENCHYMAL STEM CELLS OR EXOSOMES DERIVED THEREFROM AS ACTIVE INGREDIENT | Non-Final OA | UNIVERSITY INDUSTRY FOUNDATION, YONSEI UNIVERSITY WONJU CAMPUS |
| 18278343 | MANUFACTURING METHOD OF ARTIFICIAL SKIN USING CELLS DIFFERENTIATED FROM INDUCED PLURIPOTENT STEM CELLS | Non-Final OA | CLECELL, CO. LTD. |
| 17606414 | COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE | Non-Final OA | Amicus Therapeutics, Inc. |
| 17292296 | USE OF ECM1 GENE-KNOCKOUT MOUSE IN SCREENING OF ANTI-HEPATIC FIBROSIS DRUG | Final Rejection | CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES |
| 17600928 | CRYOPRESERVATION AND CELL CULTURE MEDIA | Final Rejection | Akron BioProducts LLC |
| 18034780 | METHOD FOR THE GENERATION OF NEUROSPHERES | Non-Final OA | KUGELMEIERS LTD. |
| 18031877 | CHEMICAL CULTURE SYSTEM AND USE THEREOF | Non-Final OA | IREGENE THERAPEUTICS LTD |
| 17999288 | SERUM-FREE INDUCTION METHOD FOR SENSORY NEURON CELL | Non-Final OA | IREGENE THERAPEUTICS LTD |
| 18296158 | BIOINK CONTAINING SELF-ASSEMBLING PEPTIDES | Non-Final OA | L’ECOLE SUPERIEURE DE CHIMIE, PHYSIQUE, ELECTRONIQUE DE LYON (CPE Lyon) |
| 17768610 | End-to-End Platform for Human Pluripotent Stem Cell Manufacturing | Non-Final OA | LONZA WALKERSVILLE, Inc. |
| 18246744 | COMPOSITIONS AND METHODS FOR INCREASING STEM CELL FUNCTION | Non-Final OA | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD |
| 17926374 | POLYPEPTIDE USEFUL IN ADOPTIVE CELL THERAPY | Non-Final OA | QUELL THERAPEUTICS LIMITED |
| 17762908 | METHOD FOR INDUCING HEPATOCYTE PLASTICITY | Final Rejection | Public University Corporation Yokohama City University |
| 17761838 | IMMUNOCYTOKINE COMPRISING HETERODYMERIC PROTEIN COMPLEX BASED ON IL-15/IL-15RA | Final Rejection | JOINT STOCK COMPANY "BIOCAD" |
| 16903975 | MITOCHONDRIAL TREATMENT OF ORGANS FOR TRANSPLANTATION | Non-Final OA | United Therapeutics Corporation |
| 17800307 | METHOD FOR CULTURING CELLS DERIVED FROM EPITHELIAL TISSUE, AND COMPOSITION CONTAINING CELLS CULTURED BY SAID CULTURE METHOD | Non-Final OA | GN Corporation Co Ltd |
| 17767176 | A MAMMALIAN-AVIAN CHIMERIC MODEL SYSTEM | Final Rejection | INNOVO MIMETICS LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy